Propanc Biopharma, Inc. (PPCB)
3.21
+2.14
(+200.00%)
USD |
NASDAQ |
Aug 27, 09:48
Propanc Biopharma Shareholders Equity (Quarterly) : 9.828M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 9.828M |
| December 31, 2025 | 10.45M |
| September 30, 2025 | 14.36M |
| June 30, 2025 | 13.91M |
| March 31, 2025 | 18.09M |
| December 31, 2024 | -4.159M |
| September 30, 2024 | -4.108M |
| June 30, 2024 | -3.779M |
| March 31, 2024 | -3.700M |
| December 31, 2023 | -3.564M |
| September 30, 2023 | -2.989M |
| June 30, 2023 | -3.117M |
| March 31, 2023 | -2.941M |
| December 31, 2022 | -2.915M |
| September 30, 2022 | -2.768M |
| June 30, 2022 | -3.024M |
| March 31, 2022 | -2.947M |
| December 31, 2021 | -2.930M |
| September 30, 2021 | -2.307M |
| June 30, 2021 | -3.068M |
| March 31, 2021 | -3.004M |
| December 31, 2020 | -3.608M |
| September 30, 2020 | -3.236M |
| June 30, 2020 | -3.641M |
| March 31, 2020 | -4.847M |
| Date | Value |
|---|---|
| December 31, 2019 | -5.672M |
| September 30, 2019 | -4.542M |
| June 30, 2019 | -4.301M |
| March 31, 2019 | -3.413M |
| December 31, 2018 | -3.904M |
| September 30, 2018 | -5.558M |
| June 30, 2018 | -6.752M |
| March 31, 2018 | -6.773M |
| December 31, 2017 | -7.149M |
| September 30, 2017 | -6.738M |
| June 30, 2017 | -5.442M |
| March 31, 2017 | -4.715M |
| December 31, 2016 | -3.841M |
| September 30, 2016 | -1.804M |
| June 30, 2016 | -2.565M |
| March 31, 2016 | -3.521M |
| December 31, 2015 | -3.356M |
| September 30, 2015 | -3.182M |
| June 30, 2015 | -3.054M |
| March 31, 2015 | -1.851M |
| December 31, 2014 | -1.877M |
| September 30, 2014 | -1.784M |
| June 30, 2014 | -1.408M |
| March 31, 2014 | -1.165M |
| December 31, 2013 | -1.050M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.33M |
| Total Liabilities (Quarterly) | 4.506M |
| Debt to Equity Ratio | 0.1601 |
| Current Ratio | 2.366 |
| Net Debt Paydown Yield | -3.54% |